| HOME | |
| About Western | |
| > | Location |
| > | Contact Us |
| Technology Areas | |
|
> |
Colposcopy |
| > | GI Bleeding |
| > | IBS |
|
> |
Melanoma |
| > | Newborn Screening |
| > | NUD |
| Products | |
| > | DermAlert® |
| > | Enterotach® |
|
> |
Premium Software |
| News | |
| > | Press Release |
| > | Events |
| > | Publications |
-Medical
Products Development since 1984|
Western Research Company, Inc
specializes in the application of computer technology to the
solution of clinically relevant problems. **News** - WRC receives grant for studying home-based screening for melanoma with DermAlert® Major funding provided through grants from the National Institutes of Health (NIH), with particular credit to:
|
|||||
| Our Current Showcased Projects Are... | |||||
| melanoma research program | computerized auscultation |
results with Enterotach® system(view poster) MED Foundation is a nonprofit group increasing the accessibility of whole body photography to those at risk: MEDFndn.org |
|||
 The alarming rise in melanoma has motivated WRC to develop Dermalert®. This imaging software provides a powerful means to help individuals detect new or changing moles that may signal a melanoma. [ melanoma risk by geographical location] |
The EnteroTach® system
provides a means of obtaining quantitative and objective measurements
characterizing the occurrence of gastrointestinal sounds.
|
||||
|
|
|||||
The HemeAlert® technology uses a spectroscopic
approach for a rapid and economical analysis of blood present in fecal
samples. The HemeAlert® test is not only sensitive but is capable of
determining whether the blood in a stool sample originated from a bleeding
site in the upper or lower GI tract. This capability will add an important
capability for the economical screening for colorectal cancer.